Home LiteratureArticle Details
PMID: 15170446 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Exploiting tumour hypoxia in cancer treatment.

Nature reviews. Cancer ·Vol. 4 ·No. 6 ·2004-06-00 ·Pages 437-47

Brown JM, Wilson WR

Abstract

暂无摘要

MeSH Terms
Bacteria, Anaerobic/physiology Cell Hypoxia DNA-Binding Proteins/pharmacology,therapeutic use Drug Resistance, Neoplasm Genetic Therapy Helix-Loop-Helix Motifs Humans Hypoxia-Inducible Factor 1 Hypoxia-Inducible Factor 1, alpha Subunit Necrosis Neoplasms/physiopathology,therapy Nuclear Proteins/pharmacology,therapeutic use Prodrugs Transcription Factors
Chemicals
DNA-Binding Proteins HIF1A protein, human Hypoxia-Inducible Factor 1 Hypoxia-Inducible Factor 1, alpha Subunit Nuclear Proteins Prodrugs Transcription Factors
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Brown J Martin
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford, California 94305, USA. mbrown@stanford.edu
Wilson William R
Article Info
Journal
Nature reviews. Cancer
Abbr.
Nat Rev Cancer
ISSN
1474-175X
DOI
10.1038/nrc1367
Email
mbrown@stanford.edu
Published
2004-06-00
Pages
437-47
Language
English
Region
England
NLM ID
101124168
Subset
IM
External Links
PubMed source DOI: 10.1038/nrc1367 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2